京新药业：公司即将发行H股股票并在香港联合交易所有限公司上市

Core Viewpoint - Jingxin Pharmaceutical announced plans to issue overseas listed shares (H-shares) and apply for listing on the main board of the Hong Kong Stock Exchange to enhance its global strategy, international image, and overall competitiveness [1]. Group 1 - The company aims to deepen its globalization strategy [1] - The issuance of H-shares is part of the company's efforts to improve its international image [1] - The listing on the Hong Kong Stock Exchange is intended to increase the company's comprehensive competitiveness [1]